Sciton has been recognised by MedTech Outlook Magazine as one of the Top 10 Gynaecology Providers – 2019.
The magazine says, ‘In recent years, the advancements in imaging technology, endoscopic equipment, drug treatment, and scientific innovation have contributed to substantial progress in gynaecology. That being said, there has been a change in the attitudes and practice of gynaecologists as a result of the significant expectations and knowledge of their patients. It is predominantly recognized that gynecological problems affect the quality of life of women in different ways. Thus, highlighting the value and importance of patient assessed health status measures to evaluate the subjective severity and treatment of common gynecological conditions.
With the developing growth of camera and monitoring technology, the new single-chip cameras provide images as good as the triple-chip cameras. This level of clarity is enabling anatomically challenging areas to be entirely feasible and possible using advanced laparoscopic surgical dissection. However, the noteworthy current trend in gynecologic surgery is a more minimally invasive surgical approach with shorter hospital stays, fasted patient recovery, less blood loss, fewer infection, and increased patient satisfaction. More recently, robot-assisted management of gynecologic malignancies has been described as a promising new technique that may overcome the operational limitations seen with conventional laparoscopy.
This edition of MedTech Outlook features companies that are at the forefront of offering robust gynecology technological solutions like FemCap, Relevium Labs, Sciton, and many more. MedTech Outlook’s editorial board has assessed and shortlisted some of the most prominent organizations in the industry that solve challenges by implementing the current technological trends in the gynecology field. We present to you—“ Top 10 Gynecology Solution Providers – 2019”.’
"In such a competitive scenario, Sciton understands a woman’s most innate and intimate problems and addresses them with a series of options"
Or read the article at MedTech Outlook Magazine.